Long-term treatment costs and cost-effectiveness of restoration repair versus replacement

被引:7
|
作者
Kanzow, Philipp [1 ]
Krois, Joachim [2 ]
Wiegand, Annette [1 ]
Schwendicke, Falk [2 ]
机构
[1] Univ Med Ctr Gottingen, Dept Prevent Dent Periodontol & Cariol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Charite Univ Med Berlin, Dept Oral Diagnost Digital Hlth & Hlth Serv Res, Berlin, Germany
关键词
Composite materials; Cost-effectiveness; Minimally invasive dentistry; Restoration repair; Restorative dentistry; Treatment costs; POSTERIOR COMPOSITE RESTORATIONS; LONGEVITY; MOLARS; CARE;
D O I
10.1016/j.dental.2021.02.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives. When managing partially defective restorations, dentists can choose between repair and replacement. We aimed to assess the long-term treatment costs of repairs and replacements. Methods. Partially defective anterior and posterior composite restorations in permanent teeth had been repaired or replaced in a German university hospital and were retrospectively followed until censoring or one of the following events: (1) Extraction, (2) Major complications including placement of indirect restorations, endodontic treatments and extractions, or (3) Any complications including major complications and further direct restorations. Costs were estimated from a German mixed public-private-payer perspective. Cost-effectiveness differences were described using median-based incremental-cost-effectiveness ratios (ICERMEDIAN). Statistical analysis was performed using generalized linear mixed modeling (GLM), Chi(2)-test, and Wilcoxon rank-sum test (p < 0.05). Results. A total of 616 repairs in 468 patients (follow-up: 4.9 +/- 4.1 years) and 264 replacements in 218 patients (follow-up: 4.8 +/- 4.3) were included. While replacements were associated with higher initial treatment costs, median annualized treatment costs did not significantly differ between repair (47.58 Euro [IQR: 24.41-107.04]) and replacement (50.64 Euro [IQR: 26.30-118.78]; p > 0.05), but were higher for molars (75.53 Euro [IQR: 24.41-92.18]) than incisors (45.03 Euro [IQR: 28.19-168.50]; p = 0.011). The difference in the % of extractions, major and any complications were minimal between both groups. The mean ICERMEDIAN of replacement vs. repair was -146.8 Euro/% when extractions were considered as outcomes. Regarding major and any complications, mean ICERMEDIAN amounted to 67.6 Euro/% and 23.9Euro/%, respectively. Significance. Repairs and replacements of partially defective restorations showed similar long-term costs and cost-effectiveness. (C) 2021 The Academy of Dental Materials. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E375 / E381
页数:7
相关论文
共 50 条
  • [21] LONG-TERM COST-EFFECTIVENESS OF LASMIDITAN, UBROGEPANT AND RIMEGEPANT FOR TREATMENT OF ACUTE MIGRAINE
    Touchette, D.
    Atlas, S. J.
    Agboola, F. O.
    Joshi, M.
    Lee, T. A.
    Chapman, R. H.
    Pearson, S. D.
    Rind, D. M.
    VALUE IN HEALTH, 2020, 23 : S261 - S261
  • [22] Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
    O'Day, Ken
    Rajagopalan, Krithika
    Meyer, Kellie
    Pikalov, Andrei
    Loebel, Antony
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 459 - 470
  • [23] Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis
    Beresniak, Ariel
    Sabatier, Brigitte
    Achouh, Paul
    Menasche, Philippe
    Fabiani, Jean-Noel
    ANNALS OF THORACIC SURGERY, 2013, 95 (01): : 98 - 104
  • [24] Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand
    Thompson, Kelly J.
    Young, Paul J.
    Venkatesh, Balasubramanian
    Cohen, Jeremy
    Finfer, Simon R.
    Grattan, Sarah
    Hammond, Naomi E.
    Jan, Stephen
    Li, Qiang
    Di Tanna, Gian Luca
    McArthur, Colin
    Myburgh, John
    Rajbhandari, Dorrilyn
    Taylor, Colman B.
    AUSTRALIAN CRITICAL CARE, 2022, 35 (03) : 241 - 250
  • [25] Cost-effectiveness of a Ceram de Infused Skin Barrier Versus a Standard Barrier Findings From a Long-Term Cost-effectiveness Analysis
    Berger, Ariel
    Inglese, Gary
    Skountrianos, George
    Karlsmark, Tonny
    Oguz, Mustafa
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2018, 45 (02) : 146 - 155
  • [26] COST-BENEFIT-ANALYSIS VERSUS COST-EFFECTIVENESS ANALYSIS FOR THE EVALUATION OF LONG-TERM CARE PROGRAMS
    TORRANCE, GW
    STODDART, GL
    DRUMMOND, MF
    GAFNI, A
    HEALTH SERVICES RESEARCH, 1981, 16 (04) : 474 - 476
  • [27] The Costs of Depression and the Cost-Effectiveness of Treatment
    Koenig, Hans-Helmut
    Luppa, Melanie
    Riedel-Heller, Steffl
    PSYCHIATRISCHE PRAXIS, 2010, 37 (05) : 213 - 215
  • [28] Schizophrenia costs and treatment cost-effectiveness
    Knapp, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 : 15 - 18
  • [29] The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension
    van Gestel, Aukje
    Schouten, Jan S. A. G.
    Beckers, Henny J. M.
    Severens, Johan L.
    Hendrikse, Fred
    Webers, Carroll A. B.
    ACTA OPHTHALMOLOGICA, 2014, 92 (06) : 513 - 523
  • [30] Cost-effectiveness of long-term treatment of hypertension with irbesartan vs. losartan or no treatment in Denmark
    Knudsen, M. S.
    Lange, M.
    Dahl, E.
    VALUE IN HEALTH, 2006, 9 (06) : A348 - A348